BE1013559A6 - Composition pharmaceutique contenant du citalopram. - Google Patents

Composition pharmaceutique contenant du citalopram. Download PDF

Info

Publication number
BE1013559A6
BE1013559A6 BE2001/0537A BE200100537A BE1013559A6 BE 1013559 A6 BE1013559 A6 BE 1013559A6 BE 2001/0537 A BE2001/0537 A BE 2001/0537A BE 200100537 A BE200100537 A BE 200100537A BE 1013559 A6 BE1013559 A6 BE 1013559A6
Authority
BE
Belgium
Prior art keywords
citalopram
crystals
unit dosage
dosage form
solid unit
Prior art date
Application number
BE2001/0537A
Other languages
English (en)
French (fr)
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE1013559(A6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of BE1013559A6 publication Critical patent/BE1013559A6/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE2001/0537A 2000-08-10 2001-08-10 Composition pharmaceutique contenant du citalopram. BE1013559A6 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (1)

Publication Number Publication Date
BE1013559A6 true BE1013559A6 (fr) 2002-03-05

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2001/0537A BE1013559A6 (fr) 2000-08-10 2001-08-10 Composition pharmaceutique contenant du citalopram.

Country Status (34)

Country Link
EP (1) EP1318805A2 (no)
JP (1) JP2003531153A (no)
KR (1) KR20030024833A (no)
CN (1) CN1446089A (no)
AR (1) AR030095A1 (no)
AT (1) AT5744U1 (no)
AU (2) AU2001100198B4 (no)
BE (1) BE1013559A6 (no)
BG (1) BG107578A (no)
BR (1) BR0113250A (no)
CA (1) CA2353693C (no)
CH (2) CH694241A5 (no)
CZ (1) CZ2003397A3 (no)
DE (2) DE20113195U1 (no)
EA (1) EA200300247A1 (no)
ES (1) ES2172481B2 (no)
FI (1) FI5176U1 (no)
FR (1) FR2812811B1 (no)
GB (1) GB2368014B (no)
GR (1) GR1004193B (no)
HR (1) HRP20030054A2 (no)
HU (1) HUP0103071A3 (no)
IE (1) IES20010693A2 (no)
IL (1) IL154050A0 (no)
IS (1) IS6021A (no)
IT (1) ITMI20011637A1 (no)
MX (1) MXPA03000837A (no)
NL (1) NL1018741C1 (no)
NO (1) NO20013891L (no)
NZ (1) NZ523785A (no)
PL (1) PL359824A1 (no)
SK (1) SK2842003A3 (no)
WO (1) WO2001080619A2 (no)
YU (1) YU9003A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
MXPA05005772A (es) * 2002-12-23 2005-08-16 Lundbeck & Co As H Bromhidrato de escitalopram y un metodo para su preparacion.
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106397249A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种高稳定性lcz696结晶粉末及其制备方法
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
IES20010693A2 (en) 2002-07-10
CH694241A5 (de) 2004-10-15
EP1318805A2 (en) 2003-06-18
WO2001080619A3 (en) 2002-02-21
AT5744U1 (de) 2002-11-25
FI5176U1 (fi) 2001-12-27
JP2003531153A (ja) 2003-10-21
SK2842003A3 (en) 2003-09-11
CA2353693C (en) 2003-07-22
EA200300247A1 (ru) 2003-06-26
IL154050A0 (en) 2003-07-31
FR2812811A1 (fr) 2002-02-15
HUP0103071A2 (hu) 2002-05-29
MXPA03000837A (es) 2003-06-06
FR2812811B1 (fr) 2006-08-18
WO2001080619A2 (en) 2001-11-01
AU2001100198A4 (en) 2001-08-16
AU2001100198B4 (en) 2002-06-13
DE20113195U1 (de) 2001-11-15
NO20013891D0 (no) 2001-08-09
ES2172481A1 (es) 2002-09-16
GR20010100377A (el) 2002-09-06
PL359824A1 (en) 2004-09-06
CZ2003397A3 (cs) 2003-06-18
GB2368014A (en) 2002-04-24
AU2001279591A1 (en) 2001-11-07
KR20030024833A (ko) 2003-03-26
AR030095A1 (es) 2003-08-13
CA2353693A1 (en) 2002-01-22
HU0103071D0 (en) 2001-10-28
NO20013891L (no) 2002-02-11
HRP20030054A2 (en) 2005-02-28
IS6021A (is) 2001-10-20
CH694242A5 (de) 2004-10-15
GR1004193B (el) 2003-03-24
GB2368014B (en) 2004-06-23
HUP0103071A3 (en) 2002-12-28
NZ523785A (en) 2004-09-24
GB0118579D0 (en) 2001-09-19
DE10139115A1 (de) 2002-03-28
BR0113250A (pt) 2003-06-24
ES2172481B2 (es) 2004-08-01
NL1018741C1 (nl) 2002-02-12
ITMI20011637A1 (it) 2003-01-27
ITMI20011637A0 (it) 2001-07-27
CN1446089A (zh) 2003-10-01
BG107578A (bg) 2003-09-30
YU9003A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
US7420069B2 (en) Crystalline composition containing escitalopram
BE1013559A6 (fr) Composition pharmaceutique contenant du citalopram.
AU2002355624A1 (en) Crystalline composition containing escitalopram
US20050053652A1 (en) Pharmaceutical composition containing citalopram
US20030232881A1 (en) Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
US7420068B2 (en) Crystalline composition containing escitalopram
ZA200300561B (en) Pharmaceutical composition containing citalopram.
GB2376233A (en) Crystals of a pharmaceutically acceptable salt of citalopram wherein the median particle size of the crystals is at least 40 microns
ZA200406461B (en) Venlafaxine besylate
MXPA06009976A (en) Crystalline composition containing escitalopram oxalate

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: H. *LUNDBECK A/S

Effective date: 20070810